The
Corporate University
University Inc. The Corporate Corruption of Higher
Education. By Jennifer Washburn. Basic Books, 2005.
Reviewed By John K. Wilson
In University Inc., journalist
Jennifer Washburn takes a critical look at corporate influences
on colleges and universities, and the “wholesale culture shift”
in higher education caused by the profit motive.
One key example occurred
in 1998, when Novartis (now part of Syngenta) gave Berkeley $25
million over five years to fund research in the Department of Plant
and Microbial Biology, along with the first right to negotiate licenses,
and two out of five seats on the department’s research committee,
which determines how money gets used. The six member committee monitoring
the agreement included three Novartis representatives and two administrators
who had negotiated it for Berkeley.(31)
Under pressure from critics,
Berkeley agreed to allow an independent research team from Michigan
State University to examine the results of the deal. Their 2004
report concluded that the alliance was “outside the mainstream
for research contracts with industry.”(35)
One of the loudest opponents
of the deal was Ignacio Chapela, an assistant professor of microbial
ecology—even though Chapela had actually worked for Novartis
before coming to Berkeley.(21) In 2001, Chapela published a study
in Nature showing that DNA from genetically-modified corn was being
found in native Mexican corn, despite a ban on GM plants. Chapela
was roundly attacked by the scientists who worked for biotech companies,
and Nature was pressured to run an editorial note retracting its
support for the article. Although Chapela’s research was speculative
in parts, his work was never disproven.
Chapela’s colleagues
voted 32-1 in favor of tenure, and an ad hoc tenure committee of
experts unanimously supported tenure. But the budget committee opposed
tenure, although one genetics professor, Jasper Rine, turned out
to have ties with the biotech industry. With the budget committee’s
help, the Berkeley administration found it easy to deny Chapela
and remove a thorn from its side.(38-39)
One tactic corporations
have used to control research is to force scientists to sign confidentiality
agreements. If the research shows a drug is effective, it will be
widely publicized; if the research shows a drug is ineffective or
dangerous, the company can quash it. Betty Dong, a research at the
University of California at San Francisco, was hired by Boots Pharmaceutical
to study their thyroid medication, Synthroid. Dong discovered in
1990 that generic drugs were just as effective as Synthroid. But
because of litigation, it took nine years before the study finally
appeared in the Journal of the American Medical Association. The
company sold billions of dollars of drugs before the secret about
the study was revealed.(45)
When Brown University
medical professor David Kern tried to present research in 1996 linking
a rare lung ailment with the workplace of a company called Microfibres,
the company threatened to sue, citing an old confidentiality agreement.
Brown University officials refused to allow Kern to discuss his
research, and then immediately shut down Kern’s occupational
health program. In 1997, Kern presented his research despite the
threats against his; his teaching and research positions at Brown
University were eliminated, although the Centers for Disease Control
officially recognized the new disease Kern had identified. For Brown
University and Memorial Hospital, there was nothing to gain from
research putting a valued company in a negative light. Microfibres’
owner and two relative sat on the hospital’s board, and the
company had helped to fund the hospital’s histology lab and
hoped that Microfibres would donate even more.
Washburn also examines
the history of academic freedom in America, including the professors
fired for expressing dissenting views that offended the businessmen
who served as trustees, such as the infamous cases of Edward Bemis
at the University of Chicago in 1895 and Edward Ross at Stanford
University in 1900. But direct corporate interference in academic
freedom was fairly rare, as in 1924, when the AAUP reported how
the Phelps-Dodge Corporation pressured the University of Arizona
to fire an agriculture professor who had testified before the state
legislature about the harm caused by copper smelting fumes.(73)
The Bayh-Dole Act reshaped
American universities in the 1980s, creating a massive increase
in patents granted to colleges (from 264 in 1979 to over 3,200 in
2001) and much greater use of universities as research labs for
corporate America. Many safeguards for the legislation, including
limits on exclusive licenses and a fee for government-funded research,
were left out of the act. Universities in turn began to build expensive
new labs, hoping to garner some of the research and patent money.
The university, long home for basic scientific research, began a
rapid pursuit of the quick buck.
Corporate influences
also undermine the culture of sharing essential to scientific advances.
In one study, scientists seeking to commercialize research were
three times as likely to delay publication for more than three months,
and more than twice as likely to refuse to share information with
other academics.(124) When taxpayers paid University of Utah researchers
$4.6 million to discover a gene linked to breast cancer, the university
patented it and gave exclusive rights for its use to a company started
by a Utah professor. The company even threatened legal action against
University of Pennsylvania genetics professor Haig Kazazian when
he tried to use the gene in his research to help save lives.(3)
As Washburn points out,
the leaders of the AAUP and the movement for academic freedom realized
a century ago that faculty needed security, due process, and faculty
control of academic issues. Today, this system is at risk due to
overreliance on adjunct instructors, and academic freedom is at
stake. As Washburn notes, “By dismantling this system, universities
risk not only diminishing the quality of instruction but imperiling
this ideal.”(307)
Washburn explains, “To
the extent that universities view themselves first as drivers of
economic development, and only second as educational institutions,
their priorities will be skewed, and they will neglect their commitment
to the life of the mind.”(338) Facing the carrot of corporate
money and the stick of decreased state funding, American higher
education is entering a new era where the warnings of University
Inc. need to be followed.
|